The PennZone

  • Home
  • Health
  • Non-profit
  • Business
  • Services
  • Technology
  • Sports
  • Construction
  • Books

OnPacePlus Announces the Release of CoviSecure
The PennZone/10148683

Trending...
  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Harry Hayman Celebrates Years of WHYY Coverage, Partnership & Shared Commitment to Philadelphia
  • Together We Dance Foundation Announces Transformational Support from NAC Have a Heart Foundation
Product helps public and private entities
manage disease status enabling a safe return to work/school

WEST CHESTER, Pa. - PennZone -- Faced with an evolving pandemic and continued vaccine hesitancy, workplaces, schools, and other organizations are searching for solutions to help them manage their risk and get back to normal. OnPacePlus, a leading provider of solutions for empowering patients and medical providers announces the availability of our CoviSecure risk management product. CoviSecure provides tracking of exposure, symptoms, vaccine status, contact tracing and quarantine status for any organization needing help managing risk for their workforce, students or other population. In partnership with Mathematica, CoviSecure leverages Mathematica's 19&Me algorithm providing an individual their personalized risk score for COVID-19. Using CoviSecure individuals and communities can assess their safety in their return to the workplace or school.

CoviSecure is delivered as a series of quick and easy interviews on a mobile phone, tablet, or computer browser. The interviews can be completed in less than a minute, providing real-time status information to individuals and the organization. The data can be leveraged to navigate a safe return or to manage overall risk factors requiring further action.

More on The PennZone
  • The 22% Tax Reality: Finland's New Gambling Law Creates a "Fiscal Trap" for Grey Market Casino Players
  • Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
  • Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion
  • Golden Paper Launches a New Chapter in Its Americas Strategy- EXPOPRINT Latin America 2026 in Brazil
  • UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote

Dr. Christopher Williams, founder and CEO of OnPacePlus commented, "In developing CoviSecure, we sought input from a variety of doctors, corporate risk managers, and educational institutions to craft a product that would help mitigate the pandemic's effects on both public and private institutions. We developed product features to allow ease of use and the efficient capture of critical information empowering real-time decisions on workforce management. Using CoviSecure, organizations can manage risk efficiently and make informed decisions that help save time, precious resources, and ultimately lives."

CoviSecure provides an individual's personalized risk score following each interview, based on an advanced algorithm created by Mathematica, a premiere research and digital services organization with expertise at the intersection of data, methods, policy, and practice headquartered in Princeton, NJ and with offices throughout the U.S. and abroad.

The product is now widely available, affordably priced, and ready for implementation within your organization.

For more information, please contact OnPacePlus at (800) 428-4844 or by email at getcovisecure@onpaceplus.com.

Contact
Dave Davis
***@onpaceplus.com


Source: OnPacePlus
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Guests Can Save 25 Percent Off Last Minute Bookings at KeysCaribbean's Village at Hawks Cay Villas
  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park
  • Together We Dance Foundation Announces Transformational Support from NAC Have a Heart Foundation
  • Harry Hayman Celebrates Years of WHYY Coverage, Partnership & Shared Commitment to Philadelphia
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Stockwell Elastomerics expands micro molding capabilities
  • Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
  • Leimert Park Announces Weeklong Kwanzaa Festival & Kwanzaa Parade Celebrating Black History, Culture, and Community
  • Schmuck Lumber Ace Hardware Opens New Greenhouse Addition
  • Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
  • Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
  • Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
  • UK Financial Ltd Launches U.S. Operations Following Delaware Approval
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
  • Top Tips for Hiring HVAC Contractors in Philadelphia

Popular on PennZone

  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 166
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 147
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
  • New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • SIMM Capital Fund Surpasses $25M Raised and $100M+ in Real Estate Assets
  • Twin Flame Visions Disrupts the Industry With Record Ad Performance and Rapid User Growth
  • Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."

Similar on PennZone

  • OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
  • 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
  • A Well-Fed World, Youth Climate Save and PAN International Launch PHRESH: A Global Directory of Plant-Based Hunger Relief Organizations
  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us